Evidence map›Paper›PMID 31074515›Full record

ArticleAnnals of the New York Academy of Sciences2019

Grape-derived polyphenols produce antidepressant effects via VGF- and BDNF-dependent mechanisms.

Cheng Jiang, Emmy Sakakibara, Wei-Jye Lin, Jun Wang, Giulio M Pasinetti, Stephen R Salton

Open access · greenAbstract read
In one paragraph

Article in Annals of the New York Academy of Sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Frontiers in pharmacology · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Progress in regulatory peptide research.Annals of the New York Academy of Sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Cheng JiangDepartment of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York.ORCID 0000-0003-4583-3295
Emmy SakakibaraDepartment of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York.
Wei-Jye LinDepartment of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York.
Jun WangDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York.
Giulio M PasinettiDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York.
Stephen R SaltonDepartment of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York.ORCID 0000-0003-4087-8427
Icahn School of Medicine at Mount Sinai · USAllen Institute for Brain Science · USSun Yat-sen University · CN

Funding

Pasinetti: Project 3; Role of Microbiome in Promotion of Cognitive and Psychological Resilience (Faith)P50AT008661 · NCCIH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FAITH, JEREMIAH JAMES · 2015 to 2019
$11.2M
Systems modeling of shared and distinct molecular mechanisms underlying comorbid Major Depressive Disorder and Alzheimer's diseaseR01AG062355 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI EHRLICH, MICHELLE E, SALTON, STEPHEN R · 2018 to 2022
$4.7M
SYSTEMATIC DRUG REPURPOSING TARGETING IMMUNE ACTIVATION NETWORKS IN ALZHEIMER'S DISEASE (AD)RF1AG059319 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI EHRLICH, MICHELLE E, GANDY, SAMUEL E. · 2018 to 2018
$4.2M
VGF function in depression and antidepressant treatmentR01MH086499 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SALTON, STEPHEN R · 2010 to 2014
$2.1M
Human VGF Polymorphisms and DepressionR21MH083496 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SALTON, STEPHEN R · 2008 to 2009
$339k
Human VGF Polymorphisms and DepressionR33MH083496 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SALTON, STEPHEN R · 2010 to 2010
$254k
BLR&D Research Career Scientist Award ApplicationIK6BX003785 · VA · JAMES J PETERS VA MEDICAL CENTER · PI PASINETTI, GIULIO MARIA · 2017 to 2025
–
BLRD VA IK6 BX003785NCCIH NIH HHS P50 AT008661NIA NIH HHS R01 AG062355NIA NIH HHS RF1 AG059319NIMH NIH HHS R01 MH086499NIMH NIH HHS R21 MH083496NIMH NIH HHS R33 MH083496
6 · The paper itself

Abstract

Recent studies suggest that bioactive dietary polyphenol preparation (BDPP) and individual polyphenolic compounds ameliorate stress-induced depression-like behaviors, but the underlying molecular mechanisms are incompletely understood. VGF (non-acronymic) in the dorsal hippocampus (dHc) has been shown to play a role in depression-like behaviors and antidepressant efficacy, and the VGF-derived peptide TLQP-62 (named by the N-terminal 4 amino acids and length) infused into dHc has been shown to have antidepressant efficacy that is BDNF-TrkB dependent. Here, we investigated whether BDPP influences VGF expression in the dHc, and whether dHc VGF is required for BDPP antidepressant efficacy. We found that BDPP produced antidepressant-like effects in naive mice and reversed the depression-like behaviors induced by chronic variable stress. In addition, we found that BDPP had no detectable antidepressant efficacy in floxed mice with prior knockdown in the dHc of either VGF or BDNF, achieved by adeno-associated virus-Cre infusion. Our data indicate that dHc VGF and BDNF expression are required for the antidepressant actions of BDPP, and therefore suggest that a VGF(TLQP-62)-BDNF-TrkB autoregulatory feedback loop could play a role in the regulation of BDPP antidepressant efficacy, much as it has been suggested to function in the antidepressant efficacies of ketamine and TLQP-62.

Indexed as

AnimalsAntidepressive AgentsBrain-Derived Neurotrophic FactorMaleMicePolyphenolsVitisAntidepressive AgentsBrain-Derived Neurotrophic FactorPolyphenolsantidepressantbrain-derived neurotrophic factor (BDNF)chronic variable stress (CVS)grape seed polyphenolic extract (GSPE)major depressive disorder (MDD)polyphenol

Identifiers

PMID31074515
PMCPMC6834858
OpenAlexW2944567251

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.